Assessment of Breast Cancer Patients Satisfaction and Health Related Quality of Life Outcomes

Breast Cancer Female Clinical Trial

Official title:

Prospective Evaluation of Patient Reported Outcomes and Satisfaction With Education in Breast Cancer Patients (PROS)

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03333122
• Other study ID #: 11056
• Status: Recruiting
• Start date: October 31, 2017
• Est. completion date: October 2027

Study information

• Verified date: March 2024
• Source: Henry Ford Health System
• Contact: Wing Lee Cheung
• Phone: 313-916-1074
• Email: wcheung1[@]hfhs.org
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The purpose of the study is to learn more about the quality of life and satisfaction with breast cancer surgical treatment and education from patient reported outcome data. The data and information obtained from breast cancer patients can be invaluable in counselling patients with a new diagnosis of breast cancer on their expected outcomes and results. The hypothesis is that using prospectively obtained data to guide surgical decision-making and optimize access to surgical procedures would improve the treatment of patients and would most likely positively impact the health-related quality of life in patients.

Description:

This study will be a prospective observational study of women with newly diagnosed breast cancer. To date, there is little data in the literature assessing and comparing the outcomes associated with breast cancer surgical procedures. Information of satisfaction of patients with treatment, result, and breast cancer education they receive is particularly deficient. Therefore, breast cancer female patients will be recruited at Henry Ford Health System. Participants will voluntarily complete surveys electronically at specific points during their treatment and recovery process. Responses and satisfaction of quality of life will be collected and analyzed.

The BREAST-Q survey will be used to obtain patient reported outcomes.The surveys will be given preoperatively, at six months, one year, two years, and five years. Specific surveys will be given to the patients based on the treatment modality they receive.The groups are breast conserving therapy, mastectomy along, and mastectomy with reconstruction.The mastectomy with reconstruction group will be further subdivided based on implant or autologous tissue reconstruction. A survey adapted from the 'Patient Satisfaction with Cancer Treatment Education (PS-CaTE)' questionnaire will be administered at the preoperative and one year time point to evaluate satisfaction with their breast cancer education. PS-CaTE consists of two parts. Part one evaluates the patient's perception of the breast cancer education. Part two serves to elucidate the primary information sources the patients utilized by the patients. A demographic survey will also be given to patients preoperatively and postoperatively. Survey results will be analyzed to detect differences in health-related quality of life among the different treatments.

BREAST-Q surveys are health-related quality of life survey instruments developed to allow validated and reliable acquisition of patient reported outcomes.These surveys were meticulously crafted following internationally accepted guidelines as established by the Scientific Advisory Committee of the Medical Outcomes Trust and the U.S. Food and Drug Administration. The item list of this survey was developed from patient interviews, focus groups, expert panels, and literature review. Separate modules were developed for each treatment modality and include BREAST-Q Breast Conserving Therapy, BREAST-Q Mastectomy, BREAST-Q Reconstruction. These surveys have been used in major trials including the United Kingdom's National Health Service survey of 8,000 patients with mastectomy and mastectomy with reconstruction and FDA surveillance and longitudinal follow-up of patients with silicone breast implants.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 2940
• Est. completion date: October 2027
• Est. primary completion date: October 2027
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients having surgery for breast cancer

• Treatment must be performed within the Henry Ford Health System

• Patients must be at least 18 years of age

Exclusion Criteria:

• Male gender

• Patients with non-operative management of breast cancer

• Patients who are unable to complete the surveys, either by choice or because of limited English, Spanish, or Arabic proficiency

• Patients who are unable to complete a preoperative survey

• Patients with Stage IV or metastatic disease

Related Conditions & MeSH terms

• Breast Cancer Female
• Breast Neoplasms

Locations

Country	Name	City	State
United States	Henry Ford Health System	Detroit	Michigan

Sponsors (1)

Lead Sponsor	Collaborator
Henry Ford Health System

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Compare health-related quality of life outcomes using condition specific surveys among women undergoing breast conserving therapy, mastectomy alone, or mastectomy with reconstruction	The BREAST-Q survey is used to determine differences in health-related of life between treatment groups.	Up to 5 Years
Primary	Compare patient satisfaction with their treatment and result among women undergoing breast conserving therapy, mastectomy alone, or mastectomy with reconstruction	The BREAST-Q survey is used to detect differences in patient satisfaction among the groups.	Up to 5 Years
Primary	Determine the effect of time on patient reported outcomes	Survey responses will be compared across time.	Up to 5 Years
Primary	Patient satisfaction with breast cancer education and compare with source of information and socioeconomic status	PS-CaTE survey is administered to assess patient satisfaction with breast cancer education.	Up to 1 Year